| 1 |
33992954 | Plausible drug interaction between cyclophosphamide and voriconazole via inhibition of CYP2B6. | 2021 Aug |
2 |
| 2 |
27600044 | Inhibition of Cytochrome P450 2B6 Activity by Voriconazole Profiled Using Efavirenz Disposition in Healthy Volunteers. | 2016 Nov |
5 |
| 3 |
25868557 | Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism. | 2015 Jun |
1 |
| 4 |
22232427 | Effects of the CYP2B6*6 allele on catalytic properties and inhibition of CYP2B6 in vitro: implication for the mechanism of reduced efavirenz metabolism and other CYP2B6 substrates in vivo. | 2012 Apr |
2 |
| 5 |
18837430 | Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X. | 2009 Feb |
1 |
| 6 |
19029318 | Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A. | 2009 Feb |
5 |
| 7 |
22190985 | Torsades de pointes associated with methadone and voriconazole. | 2009 |
1 |
| 8 |
17433262 | Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes. | 2007 Jun 15 |
3 |